Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012

Area of Science:

• Sports Medicine
• Anti-Doping Regulations
• Medical Ethics in Sport

Background:

• The International Olympic Committee (IOC) prohibited common medications in sports during the 1980s, creating a need for exceptions.
• Initial proposals for Therapeutic Use Exemptions (TUEs) faced resistance due to concerns about potential abuse, delaying their implementation.
• The World Anti-Doping Agency (WADA) later adopted and popularized the concept of TUEs, establishing them as a formal process.

Purpose of the Study:

• To trace the historical development and evolution of Therapeutic Use Exemptions (TUEs) in elite sports.
• To analyze the role of the IOC and WADA in establishing and refining the TUE process.
• To highlight the increasing necessity of TUEs due to changes in prohibited substance lists.

Main Methods:

• Historical review of TUE policies and their implementation within the IOC and WADA.
• Analysis of TUE approval data from 11 Olympic Games.
• Examination of changes in prohibited substance lists and their impact on TUE requirements.

Main Results:

• The concept of TUEs originated from the IOC's need to address medical conditions in athletes using prohibited substances.
• Widespread adoption and publicity of TUEs were significantly boosted by the establishment of WADA.
• A review of TUEs approved over 11 Olympic Games demonstrates their growing importance, with substances previously permitted now requiring TUEs.

Conclusions:

• The IOC and its TUE Committee (TUEC) were instrumental in developing the TUE concept.
• TUEs have evolved from a cautiously approached mechanism to a globally accepted standard in anti-doping.
• Changes in anti-doping regulations necessitate a robust TUE system to ensure athlete health and fair competition.